| View |
|
BR-1091
|
Epoetin beta
|
Recormon
|
2,000 I.U./0.3mL
|
Solution for Injection (S.C./I.V.)
|
Prescription Drug (Rx)
|
Pre-filled syringe of 0.3 mL with needle 27G ½" (Box of 6's)
|
Antianemic Preparations
|
Roche Diagnostic GmbH
|
Germany
|
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
Renewal
|
18 September 2021
|
05 November 2026
|
| View |
BR-1084_PI_01.pdf
|
BR-1084
|
Quadrivalent Seasonal Influenza Vaccine (Split)
Virion, Inactivated) 2024 Southern Hemisphere Strain.
|
Fluquadri
|
Formulation:
Each dose (0.5 mL) contains the following influenza strains*:
A/Victoria/4897/2022 (H1N1) pdm09-like strain
15 μg of HA**
(A/Victoria/4897/2022, IVR-238)
A/Thailand/8/2022 (H3N2)-like strain
15 μg of HA**
(A/California/122/2022, SAN-022)
B/Austria/1359417/2021-like strain
15 μg of HA**
(B/Michigan/01/2021, wild type)
B/Phuket/3073/2013 (B/Yamagata lineage)-like virus
15 μg of HA**
(B/Phuket/3073/2013, wild type)
*Propagated in embryonated chicken eggs
|
Suspension for Injection (IM)
|
Prescription Drug (Rx)
|
0.5 mL in 1.5 mL USP Type I borosilicate pre-filled glass syringe with bromobutyl plunger stopper, luer- lock adapter, and tip cap (Box of 5's).
|
Vaccines
|
Sanofi Pasteur
|
U.S.A
|
|
Sanofi Pasteur, Inc.
|
Zuellig Pharma Corporation
|
Monitored Release (Strain Clearance)
|
05 April 2024
|
05 April 2025
|
| View |
|
BR-1089
|
Measles, Mumps, Rubella and Varicella Vaccine (Live)
|
Proquad
|
Each dose (0.5 mL) contains: Measles virus (Edmonston B) 3.00 log TCID50* Mumps virus (Jeryl Lynn B level)4.30 log TCID50
Rubella virus (Wistar RA 27/3) 3.00 log TCID50
Varicella virus (Oka/Merck) 3.99 PFU**
*50% Tissue Culture Infectious Dose
**Plaque Forming Units
|
Lyophilized Powder For Solution For Injection (SC)
|
Prescription Drug (RX)
|
3 mL USP/Ph. Eur. Type I glass vial with grey rubber stopper and aluminum flip-off seal (as drug product) 0.7 mL in 1 mL Type I pre-filled needleless glass syringe with black rubber stopper and grey ribbed tip cap (as Sterile Water for Injection) [Box of 1's and 10's].
|
Vaccines
|
Merck Sharp & Dohme LLC
|
U.S.A
|
N/A
|
Merck Sharp & Dohme (I.A.) LLC
|
N/A
|
Initial (from Monitored Release) [Correction]
|
11 March 2024
|
09 June 2025
|
| View |
|
BR-1093
|
Alteplase
|
Actilyse
|
50 mg
|
Powder for Solution for Infusion (IV
|
Prescription Drug (RX)
|
Each box contains: Ph. Eur. Type I colourless glass vial
with bromobutyl rubber stopper and aluminium/ polypropylene, dark green flip-off seal + Type I glass vial (Sterile Water for Injection as diluent) x 50 mL
|
-
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
N/A
|
Boehringer Ingelheim (Philippines), Inc.
|
Boehringer Ingelheim (Philippines), Inc.
|
Initial (Variation)
|
19 September 2022
|
19 September 2027
|
| View |
|
BR-1096
|
Menothropin
|
Menopur
|
1200 IU
|
Lyophilized Powder For Injection (SC)
|
Prescription Drug (RX)
|
Packaging: Each box contains: 2 mL Type I glass vial with halobutyl rubber stopper closed with a flip-off seal (Powder) + Two 1 mL Type I pre-filled glass syringe barrel with halobutyl plunger stopper (Water for Injection + Metacresol as diluent) + 1 separate needle for reconstitution.
|
-
|
Ferring GmbH
|
Germany
|
N/A
|
Metro Drug, Inc.
|
Metro Drug, Inc.
|
-
|
18 March 2022
|
26 June 2025
|
| View |
|
BR-1098
|
Enoxaparin sodium
|
Lomoh-60
|
60 mg/0.6 mL
|
Solution for Injection (S.C.)
|
Prescription (Rx) Drug
|
Clear glass USP type I in pre-filled syringe of 0.6 mL packed in a blister of film PVC clear and foil grid. lacquer paper (Box of 1's)
|
Antithrombotic Agent
|
Emcure Pharmaceuticals Ltd.
|
India
|
N/A
|
Macropharma Corporation
|
Macropharma Corporation
|
Renewal (Correction)
|
17 November 2023
|
30 June 2025
|
| View |
|
BR-1099
|
Enoxaparin Sodium
|
Lomoh - 40
|
40 mg/0.4 mL
|
Solution For Injection (S.C.)
|
Prescription Drug (RX)
|
Clear glass USP type I in pre-filled syringe of 0.4 mL packed in a blister of film PVC clear and foil grid lacquer paper (Box of 1's)
|
-
|
Emcure Pharmaceuticals Ltd.
|
India
|
|
Macropharma Corporation
|
Macropharma Corporation
|
-
|
16 September 2021
|
30 June 2025
|
| View |
BR-1101_PI_01.pdf
|
BR-1101
|
Tocilizumab
|
Actemra
|
162 mg/ 0.9 mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
Packaging: 0.9 ml Solution in 1 ml Pre-Filled Syringe (Type I Glass) with a Staked-in Needle. The syringe is closed by a Rigid Needle Shield (Elastomer Seal with a Polypropylene Shell) and a Plunger Stopper (Butyl Rubber with a Fluororesin Coating) (Box of 1's and 4's).
|
-
|
Vetter Pharma-Fertigung GmbH & Co. KG
|
Germany
|
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
08 March 2022
|
28 July 2025
|
| View |
|
BR-1102
|
Insulin Human (rDNA)
|
Insuget-N
|
100 IU/mL
|
Suspension for Injection (IM/SC)
|
Prescription Drug (RX)
|
Glass vial with yellow flip-off cap x 10 mL
(Box of l's)
|
-
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
|
Getz Pharma (Phils.), Inc.
|
|
-
|
22 October 2020
|
06 January 2025
|
| View |
|
BR-1103
|
Insulin Human (rDNA)
|
Insuget-R
|
100 IU/mL
|
Suspension for Injection (IM/IV/SC)
|
Prescription Drug (RX)
|
Glass vial with yellow flip-off cap x 10 mL
(Box of l's)
|
-
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
|
Getz Pharma (Phils.), Inc.
|
|
-
|
22 October 2020
|
06 January 2025
|
| View |
|
BR-1106
|
Insulin Human (rDNA)
|
SciLin R
|
100 IU/mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (RX)
|
Clear and Colorless Glass Vial with Red Flip-off Cap x 10 mL (Box of l's)
|
-
|
Bioton S.A.
|
Poland
|
SciGen Limited
|
Metro Drug, Inc.
|
Metro Drug, Inc.
|
-
|
26 February 2021
|
28 January 2025
|
| View |
|
BR-1107
|
Insulin Human (DNA)
|
Scilin R
|
100 IU/mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (RX)
|
3mL glass cartridge
|
-
|
Bioton S.A.
|
Poland
|
SciGen Limited
|
Metro Drug, Inc.
|
Metro Drug, Inc.
|
Renewal
|
18 October 2021
|
28 January 2025
|
| View |
|
BR-1117
|
Heparin Sodium
|
Heprin
|
5000IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
5 mL Type I Clear Glass Vial (Box of 10's)
|
-
|
Gland Pharma Limited
|
India
|
N/A
|
Endure Medical, Inc.
|
Endure Medical, Inc.
|
Renewal
|
14 May 2021
|
25 May 2025
|
| View |
|
BR-1121
|
Trastuzumab
|
Herceptin
|
600 mg/ 5 mL (120 mg/ mL)
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
6 mL (Net content: 5 mL)Type I clear glass vial with butyl rubber stopper laminated with a fluoro-resin (Box of 1's)
|
-
|
F. Hoffmann-La Roche AG
|
Switzerland
|
N/A
|
Roche (Philippines) Inc.
|
Roche (Philippines) Inc.
|
Regular Renewal (Compliance)
|
07 March 2022
|
29 September 2025
|
| View |
|
BR-1122
|
Rituximab
|
Mabthera
|
1400 mg/ 11.7 mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
Type I USP/Ph. Eur. colourless glass vial sealed
with butyl rubber stopper laminated with fluoro resin film and crimped with an aluminum overseal fitted with a plastic flip-off disk x 15 mL (Box of 1's)
|
-
|
F. Hoffman-La Roche AG
|
Switzerland
|
N/A
|
Roche (Philippines) Inc.
|
Roche (Philippines) Inc.
|
Regular Renewal (Compliance)
|
18 February 2022
|
29 September 2025
|
| View |
|
BR-1123
|
Obinutuzumab
|
Gazyva
|
1 g/40 mL (25mg/mL)
|
Concentrate For Solution For Infusion (IV)
|
Prescription Drug (RX)
|
Type I Borosilicate glass vial with fluoro resign stopper and aluminum overseal with plastic flip-off disk x 40mL (Box of 1's)
|
-
|
Roche Diagnostics GmbH
|
Germany
|
N/A
|
Roche (Philippines) Inc.
|
Roche (Philippines) Inc.
|
Initial (Variation)
|
12 August 2022
|
12 August 2027
|
| View |
|
BR-1126
|
Secukinumab
|
Cosentyx
|
150 mg/mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
1 mL Type I pre-filled glass syringe with grey
bromobutyl rubber plunger stopper, stainless steel 276 12" needle and rubber needle shield, assembled in UltraSafe PassiveTM Needle Guard X100L (Box of l's and 2's)
|
-
|
Novartis Pharma Stein AG
|
Switzerland
|
N/A
|
Novartis Healthcare Philippines, Inc.
|
Novartis Healthcare Philippines, Inc.
|
Initial (from Monitored Release)
|
12 April 2022
|
06 January 2026
|
| View |
|
BR-1127
|
Secukinumab
|
Scapho
|
150 mg
|
Powder For Solution For Injection (SC)
|
Prescription Drug (RX)
|
6 mL Type I colourless glass vial with grey chlorobutyl rubber stopper and aluminum crimp with white flip-off cap (Box of 1's)
|
-
|
Novartis Pharma Stein AG, Pharmaceutical
|
Switzerland
|
N/A
|
Sandoz Philippines Corporation
|
Sandoz Philippines Corporation
|
-
|
07 April 2022
|
14 January 2026
|
| View |
BR-1125_PI_01.pdf
|
BR-1125
|
Quadrivalent Seasonal Influenza Vaccine (Split Virion,
Inactivated) Southern Hemisphere 2024 Strain.
|
Fluarix Tetra
|
Each dose (0.5 mL) contains the following influenza strains*:
A/Victoria/4897/2022 (H1N1)pdm09-like strain
(A/Victoria/4897/2022, IVR-238)
A/Thailand/8/2022 (H3N2)-like strain
(A/Thailand/8/2022, IVR-237)
B/Austria/1359417/2021-like strain
(B/Austria/1359417/2021, BVR-26)
B/Phuket/3073/2013-like strain
(B/Phuket/3073/2013, wild type) [Yamagata lineage] *Propagated in embryonated chicken eggs
**Haemagglutinin
15 μg of HA**
15 μg of HA**
15 μg of HA**
15 μg of HA**
|
Suspension for Injection (IM)
|
Prescription Drug (RX)
|
0.5 mL in 1 mL Type I pre-filled glass syringe with luer lock adapter and plastic rigid tip cap (PRTC) and 2 separate needles (25G 5/8" and 25G 1") in a plastic tray (Box of 1's).
|
Vaccines
|
GlaxoSmithKline Biologicals NL Der SmithKline
|
Germany
|
|
GlaxoSmithKline Philippines, Inc.
|
GlaxoSmithKline Philippines, Inc.
|
Monitored Release (Strain Clearance)
|
19 February 2024
|
19 February 2025
|
| View |
BR-1130_PI_01.pdf
|
BR-1130
|
Secukinumab
|
Scapho
|
150 mg/mL
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
1 mL Type I pre-filled glass syringe with grey
bromobutyl rubber plunger stopper, stainless steel 276 12" needle and rubber needle shield, assembled in an autoinjector pen with transparent window (SensoReady pen) (Box of 1's)
|
-
|
Novartis Pharma Stein AG, Pharmaceutical
|
Switzerland
|
|
Novartis Healthcare Philippines, Inc.
|
Novartis Healthcare Philippines, Inc.
|
Initial (from Monitored Release)
|
11 April 2022
|
06 January 2026
|